Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 148
Immune Disorders Drugs 79
Genomics 79
Biopharmaceuticals 79
Drug Discovery 66
Oncology Drugs 53
Biotechnology 49
Pharmaceuticals 43
Musculoskeletal Disorders Drugs 41
Hematological Drugs 38
Biosimilars and Biosuperiors 30
Cardiovascular Drugs 26
Clinical Trials 26
Alzheimer's Disease Drugs 26
Allergy and Immunology 20
Infusions and Injectables 20
Optical Disorders Drugs 19
Infectious Diseases Drugs 19
Respiratory Drugs 18
Mental Disorders Drugs 18
Gastrointestinal Drugs 17
Needles and Syringes 16
E-Healthcare 14
Psoriasis Drugs 14
Pharmaceutical Manufacturing 14
Immunosuppressive Drugs 14
Neurology 13
Healthcare Services 13
Hematology 13
Drug Delivery 12
Endocrine and Metabolic Disorders Drugs 12
Lymphoma Drugs 11
Analgesics 10
Leukemia Drugs 9
Optical 9
Diagnostics 9
Liver and Kidney Disorders Drugs 9
Therapeutic Area 8
Drugs by Therapeutic Area 7
Pulmonary Medicine 7
Medical Devices 7
Company Reports 6
Enzymes 6
Hospital Management 5
Cardiology 5
Oncology 5
Proteomics 4
Neurology Devices 4
Vaccines 4
Dermatological Drugs 4
Schizophrenia Drugs 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Pharmacoeconomics 3
Lung Cancer Drugs 3
Diabetes Devices 3
Stem Cells 3
Biomaterials 3
Mental Health 3
Vitamins and Dietary Supplements 3
Laboratory Equipment 3
Gastroenterology 3
In Vitro Diagnostics 2
Managed Care 2
Dermatology 2
Skin Cancer Drugs 2
Nanomedicine 2
Anxiety Drugs 2
Asthma Drugs 2
Urology and Nephrology 1
Women's Health 1
Fertility Services 1
Breast Cancer Drugs 1
Prostate Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Medical Imaging 1
Orthopedic Devices 1
Infectious Disease Testing 1
Computed Tomography 1
Transdermal and Transmucosal Drug Delivery 1
Biomarkers 1
Surgical Procedures 1
Contrast Media 1
Kidney Cancer Drugs 1
Antibiotics 1
Clinical Skills 1
Pediatrics 1
Anatomy 1
Allergy Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

913 Results (Page 25 of 46)
- Relevance
  Sort by

Formulation Development Outsourcing Market Size, Share & Trends Analysis Report By Service (Performulation, Formulation Development), By Formulation (Oral, Injectable), By Therapeutic area, By Region, And Segment Forecast, 2023 - 2030

 Report
March 2023
143 Pages
Global

From

€5911EUR$5,950USD£4,915GBP

Multiple Sclerosis Therapeutics - Global Strategic Business Report

 Report
November 2024
164 Pages
Global

From

€5414EUR$5,450USD£4,502GBP

Neurodegenerative Drugs - Global Strategic Business Report

 Report
November 2024
344 Pages
Global

From

€5414EUR$5,450USD£4,502GBP

Ion Channel Modulators - Global Strategic Business Report

 Report
November 2024
172 Pages
Global

From

€5414EUR$5,450USD£4,502GBP

Neurology Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
116 Pages
Global

From

€4719EUR$4,750USD£3,923GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

2022 Leading Biotechnology Companies Capabilities, Goals and Strategies

 Report
May 2022
Global

From

€4471EUR$4,500USD£3,717GBP

Oncologists Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

Gastrointestinal Diseases Therapeutics Market 2023-2027

 Report
September 2023
168 Pages
Global

From

€2484EUR$2,500USD£2,065GBP

Precision Medicine - Global Strategic Business Report

 Report
November 2024
93 Pages
Global

From

€5563EUR$5,600USD£4,626GBP

Recombinant DNA Technology - Global Strategic Business Report

 Report
November 2024
88 Pages
Global

From

€5563EUR$5,600USD£4,626GBP

Anti-Lymphotoxin - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€869EUR$875USD£723GBP

€1242EUR$1,250USD£1,032GBP

Biobetter Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2023
112 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Inflammatory Bowel Disease Treatment Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

Postpartum Health Supplements Market Size, Share & Trends Analysis Report by Product Type (Single Nutritional Supplements, Combined Nutritional Supplements), Formulation, Sales Channel, Region, and Segment Forecasts, 2024-2030

 Report
January 2024
120 Pages
Global

From

€5911EUR$5,950USD£4,915GBP

Protein Therapeutics Market 2024-2028

 Report
May 2024
191 Pages
Global

From

€2484EUR$2,500USD£2,065GBP

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a Landscape Analysis of Technologies, Targets, Business and Financing from An Industry Perspective

 Report
November 2022
418 Pages
Global

From

€2350EUR$2,534USD£2,022GBP

Antineoplastic Agents - Global Strategic Business Report

 Report
November 2024
93 Pages
Global

From

€5563EUR$5,600USD£4,626GBP

Systemic Lupus Erythematosus Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023- 2028)

 Report
April 2023
115 Pages
Global

From

€4719EUR$4,750USD£3,923GBP

Rare Disease & Orphan Therapeutic Market Analysis & Forecast to 2025

 Report
December 2020
197 Pages
Global

From

€4868EUR$4,900USD£4,047GBP

Combination Antibody Therapy - Global Strategic Business Report

 Report
November 2024
196 Pages
Global

From

€4918EUR$4,950USD£4,089GBP

913 Results (Page 25 of 46)
- 1
- 23
- 24
- 25
- 26
- 27

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.